LeaderPortfolio
Junmin
Wang Junmin
Rank #1037
CHINAHealthcarePharmaceuticals

Wang Junmin

Net Worth
$4.141B
0% (24h)
Wang Junmin is the Chairman of Haisco Pharmaceutical Group, a Tibet-based company involved in the research, development, production, and sale of a wide variety of drugs. With a net worth of $3.6 billion as of March 24, 2026, Wang has built his wealth through the pharmaceutical industry. He holds a bachelor's degree from Shenyang Pharmaceutical University and has over 4,000 employees under his leadership. His career has been marked by significant achievements since Haisco Pharmaceutical Group's founding in 2000, contributing to his status as a self-made billionaire in China.

The Full Dossier

Early Life

Wang Junmin was born in China. Information about his early life and upbringing is limited, but he pursued higher education in pharmaceutical sciences, laying the foundation for his future career.

Rise to Success

Wang Junmin's career took off with the founding of Haisco Pharmaceutical Group in 2000. The company's IPO on the Shenzhen Stock Exchange in January 2012 marked a pivotal moment, with shares more than doubling in value. He debuted as a billionaire in 2013. Since then, Wang has served as the Chairman of the company, overseeing its growth and expansion in the pharmaceutical sector.

Key Business Strategies

Haisco Pharmaceutical Group focuses on the research, development, production, and sale of various drugs. His leadership has been critical in navigating the competitive pharmaceutical landscape in China. His strategy has involved increasing R&D spending and seeking collaborations to drive innovation.

Philanthropy

Specific philanthropic initiatives and amounts are not available in the search results.

Career Timeline

2012

Haisco Pharmaceutical Group IPO

The company went public on the Shenzhen Stock Exchange, leading to a significant increase in share value.

2000

Founded Haisco Pharmaceutical Group

Wang Junmin established the Tibet-based company, which focuses on the research, development, production, and sale of various drugs.

Philanthropic Impact

Information not availableUndisclosed

Information not available

Information not available

Wealth Trajectory